Intermune Inc (ITMN) financial statements (2020 and earlier)

Company profile

Business Address 3280 BAYSHORE
BRISBANE, CA 94005
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:3871
Cash and cash equivalents191111
Short-term investments196197
Other undisclosed cash, cash equivalents, and short-term investments (307)
Receivables217
Inventory, net of allowances, customer advances and progress billings10
Inventory 10
Prepaid expense and other current assets7
Other undisclosed current assets21307
Total current assets:429332
Noncurrent Assets
Property, plant and equipment54
Intangible assets, net (including goodwill)1718
Intangible assets, net (excluding goodwill)1718
Restricted cash and investments54
Other noncurrent assets12
Prepaid expense and other noncurrent assets9
Other undisclosed noncurrent assets(5)(4)
Total noncurrent assets:3332
TOTAL ASSETS:463363
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6330
Accounts payable1719
Accrued liabilities29 
Employee-related liabilities1712
Other undisclosed current liabilities 26
Total current liabilities:6357
Noncurrent Liabilities
Long-term debt and lease obligation265240
Long-term debt, excluding current maturities265240
Liabilities, other than long-term debt00
Other liabilities00
Total noncurrent liabilities:265240
Total liabilities:328297
Stockholders' equity
Stockholders' equity attributable to parent13466
Common stock00
Additional paid in capital1,4511,164
Accumulated other comprehensive income11
Accumulated deficit(1,318)(1,098)
Total stockholders' equity:13466
TOTAL LIABILITIES AND EQUITY:463363

Income statement (P&L) ($ in millions)

12/31/2013
12/31/2012
Revenues
(Revenue, Net)
7026
Cost of revenue
(Cost of Goods and Services Sold)
(10)(9)
Gross profit:6017
Operating expenses(260)(213)
Other undisclosed operating income11
Operating loss:(199)(195)
Nonoperating income (expense)(1)0
Investment income, nonoperating01
Other nonoperating expense(2)(0)
Interest and debt expense(23)(9)
Other undisclosed income from continuing operations before equity method investments, income taxes2 
Loss from continuing operations before income taxes:(220)(203)
Income tax expense (benefit)(1)19
Loss from continuing operations:(221)(185)
Income from discontinued operations135
Net loss available to common stockholders, diluted:(220)(150)

Comprehensive Income ($ in millions)

12/31/2013
12/31/2012
Net loss:(220)(150)
Other comprehensive income (loss)0(1)
Comprehensive loss, net of tax, attributable to parent:(219)(151)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: